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Aortic angiosarcoma masquerading as a thoracic
aortic aneurysm
Vimal Ramjee, BS, and Sharif Ellozy, MD, New York, NY
Aortic angiosarcoma is an exceedingly rare clinical entity. Significant delay in diagnosis can occur due to a low index of
suspicion on the part of the clinician. We report a case of aortic angiosarcoma masquerading as a descending thoracic
aneurysm arising from a penetrating ulcer. The patient was initially treated with an endovascular stent graft for rapid
growth, but the lesion continued to enlarge despite angiographic exclusion. FDG-PET CT scan and biopsy ultimately
confirmed the diagnosis of aortic angiosarcoma. This case highlights some of the difficulties of making the early diagnosis
of aortic angiosarcoma. (J Vasc Surg 2009;50:1477-80.)Aortic sarcomas are an extremely rare, malignant entity
with fewer than 145 cases reported in the literature to date.
The clinical presentation and imaging studies frequently
mimic aneurysmal disease or aortic occlusive disease. As
such, there is often a delay in diagnosis. Despite aggressive
management, patients with aortic angiosarcomas have a
median survival time of only a fewmonths. We report a case
of a primary mural aortic angiosarcoma of the descending
thoracic aorta presenting as an enlarging aortic aneurysm in
the setting of a penetrating ulcer.
CASE PRESENTATION
A 68-year-old male presented to the hospital with
intermittent abdominal pain radiating to the left chest for
twomonths and no other complaints. Physical examination
was unremarkable. Of note, the patient experienced post-
prandial abdominal pain, as well as weight loss of approxi-
mately 20 pounds over the last ten months. His past
medical history included hypertension, hypercholesterol-
emia, asthma, and a significant smoking history of 45
pack-years.
Given the patient’s presentation and history, workup
was completed to rule out occult gastrointestinal (GI)
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dominal computed tomography (CT) scan. Although the
endoscopy and ultrasound were unremarkable, the CT scan
with contrast revealed what was presumed to be a descend-
ing thoracic aortic aneurysm secondary to a penetrating
ulcer (Fig 1). There was noted to be an eccentric outpouch-
ing of contrast associated with an intramural hematoma and
degeneration of the aorta just beyond the ulceration. The
aneurysmwas found to be above the level of the diaphragm,
terminating 2 cm proximal to the origin of the celiac axis.
Given the multiple comorbidities of this patient in the
setting of focal disease, endovascular repair was recom-
mended and electively scheduled. During this interval pe-
riod, however, the patient returned with worsening ab-
dominal pain. At this visit, the patient had a repeat
abdominal CT demonstrating a 5-mm increase in diameter
of the lesion (Fig 2). In light of the rapid growth and the
worsening epigastric pain, urgent repair was recom-
mended. The aneurysm was treated with endovascular
placement of an aortic stent-graft with no postoperative
complications (Fig 3). Two months following stent graft
repair of the aneurysm, the patient returned complaining of
new-onset back pain. A chest CT with contrast was ob-
tained showing a 2 cm interval increase in the size of the
soft tissue between the thoracic spine and the thoracic aorta
(Fig 4). Of note, there was no demonstrated endoleak or
device migration. The differential diagnosis at the time
included possible mycotic aneurysm versus a primary aortic
malignancy. Of note, the patient’s white blood cell count
(WBC) was always normal, but he had an elevated C-reactive
protein (46.7mg/L, nml 0-8) and erythrocyte sedimentation
rate (ESR; 114 mm/Hr, nml 0-15). A fluorodeoxyglucose-
positron emission tomography (FDG-PET) scan demon-
strated hypermetabolic activity in the rim of the lesion, as well
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splenic lesion was new when compared to prior CT. A CT-
guided biopsy of the mass was performed, which only
demonstrated necrotic tissue. A left video-assisted thoraco-
scopic biopsy of the lesion was completed. Exploration of
the chest revealed a large, complex, fungating mass of the
distal descending thoracic aorta that was friable. Confirma-
tion with frozen tumor section demonstrated cells consistent
with an aortic angiosarcoma invading the lung parenchyma.
Stains for cytokeratins AE1/AE3, CAM5.2, CK5/6, CD34,
CD31, S100, WT1, TTF-1, actin, and desmin were negative.
Palliative radiation and chemotherapy was discussed with the
patient, but he declined treatment and ultimately expired four
Fig 1. A computed tomography (CT) scan with contrast prior to
graft repair of patient’s presumed aneurysm. Note the eccentric
outpouching of contrast and wall thickening.
Fig 2. A preoperative computed tomography (CT) scan with
contrast one month after initial visit and workup for isolated
abdominal pain. The maximal aortic diameter measured from this
CT scan was 60 mm, 5 mm larger than before.months later.DISCUSSION
Primary aortic sarcomas are an extremely rare entity,
with fewer than 145 reported in the literature to date.1-6
Between 24 and 34 of these cases have been specifically
identified as aortic angiosarcomas.6,7 While both thoracic
and abdominal aortic sarcomas have the same incidence,
aortic angiosarcomas occur more frequently in the de-
scending thoracic aorta.1,7,8 They also occur more fre-
quently in men, with a male-to-female ratio of 2:1. The
average age of those affected is 62 years, with a range of 46
to 85 years.1,2,5-7 There are no established risk factors for
developing aortic angiosarcomas to date.9,10
Clinically, most patients with aortic sarcomas present
with symptoms that are non-specific. Symptoms are typi-
cally a result of either tumor embolization, local mass effect,
or luminal obstruction. One review of 135 aortic angiosar-
comas found that 25.9% of patients complained of pain on
presentation.2 Rare complications seen with aortic sarco-
mas are aortic rupture, cerebral infarction, deep vein
thrombosis, spontaneous paraplegia, and gastrointestinal
hemorrhage secondary to metastasis.1-7 This patient’s initial
complaints of abdominal pain and 20-lb weight loss were not
felt to be related to the lesion in the descending thoracic aorta
at the time of presentation. Part of the delay in therapy was
Fig 3. A 3-D reconstruction image status post endograft deploy-
ment demonstrating graft location in the thoracic aorta.due to the workup to exclude an occult GI malignancy.
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mal disease, arteriosclerotic aortoiliac occlusive disease, and
Fig 4. A computed tomography (CT) scan with contrast taken two
months postoperatively when the patient returned to the hospital
complaining of back pain. The lesion increased significantly in size
since the last visit to a maximal diameter of 80 mm. Of note, there is
no appreciable extravasation of contrast into the growing lesion.
Fig 5. A coronal section of the positron emission tomography
(PET) demonstrating hypermetabolic foci in the wall of the aorta
and in a single focus of the spleen.aortic sarcomas makes diagnosis challenging.4,6,7 While mostimaging modalities reveal what is presumed to be severe
mural disease, magnetic resonance angiography (MRA)
may be able to differentiate atheromatous lesions from
neoplastic tissue.MRAmay be able to distinguish these two
entities on the basis of increased enhancement of tumor by
gadolinium.5,7,11-14 To date, no specific features on im-
aging that would suggest the diagnosis of aortic sarcoma
have been reported in the literature. In our patient, the
effacement of the surrounding tissues and the rapid
growth of the lesion raise the suspicion for a malignancy;
however, these findings can also be seen in the setting of
a penetrating ulcer or a mycotic aneurysm, both of which
are much more common entities. The patient did not
manifest any clinical signs of infection, and the lesion
grew despite being excluded by the stent graft. These
facts led us to consider a primary malignancy as a possi-
bility. Once the diagnosis of a primary malignancy is
suspected, FDG-PET CT may be of clinical utility. In-
creased metabolic activity may be seen in the wall of the
aorta, and distant metastases may be identified, as was
the case in our patient.
Histological classification of aortic angiosarcomas can be
accomplished by staining for distinct tumor markers. Immu-
nohistochemical staining for pankeratins (AE1, AE3, S-100
and CAM5.2), endothelial markers (CD31, Qbend10/
CD34, WT-1, von Willebrand factor/Factor VIII-related
antigen and FLI-1), vimentin, desmin, and actin are tar-
geted to endothelial and myofibroblastic cells, which are
thought to give rise to angiosarcomas.5,6,15,16 While useful
confirmatory tests, many tumor markers have limited utility
given their vastly variable sensitivity and specificity in iden-
tifying aortic angiosarcomas. CD31 and CD34, for in-
stance, are classically regarded as highly sensitive and sp-
ecific markers for endothelial angiosarcomas but have
demonstrated inconsistent yield with 33%-92% positivity in
angiosarcomas.17,18 As such, a three-reagent immunohis-
tochemical panel of CD31, CD34, and von Willebrand
factor is recommended, as it has a higher sensitivity and
specificity in identifying endothelial angiosarcomas more
than any one individual marker.16
Treatment of aortic sarcomas has proven to be, at best,
mildly therapeutic. This is likely a combined result of a
highly aggressive cancer and nonspecific diagnostic tools
lending to late diagnosis. Treatment includes en bloc resec-
tion of affected aortic tissue and periaortic soft tissue with
graft interposition of the resected aortic segment.2,4 In
patients who are not good surgical candidates or who have
already developed distant metastases, chemotherapy and
adjuvant radiation may offer some palliation.2,5,6 The life
expectancy at the time of diagnosis is 14 to 27months, with
a mean overall survival length of 16  2.4 months and a
range of 0 to 168 months.1,2 Cumulative overall survival
rates for 111 cases of primary aortic tumors at three and five
years were 11.2% and 8%, respectively. After surgical inter-
vention, the survival rates at three and five years increased to
16.5% and 11.8%, respectively.2
The rarity of aortic angiosarcomas makes establishing a
diagnosis challenging. Clinical presentation and imaging
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giography (MRA) and PET-CT may help in establishing
the diagnosis of aortic sarcoma. Vascular pathology with
immunohistochemical stains are important confirmatory
tests in effectively identifying and managing this aggressive
and rare neoplasm.
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